Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial
Gallbladder disease cholelithiasis and cholecystitis have been reported, associated with the drug and with rapid weight loss
Gastroparesis (stomach paralysis), which has been linked to Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, and Trulicity, causes constant and severe nausea and vomiting, abdominal pain, severe dehydration, acid reflux, malnutrition, and weight loss
Differential activation and modulation of the glucagon-like peptide-1 receptor by small molecule ligands
Their effectiveness in the long run requires their combination with the following: Healthy eating habits Regular physical activity Ongoing medical supervision The weight loss from GLP-1 drugs must be slow and sustainable rather than quick and erratic
For a deep dive, see our article Orforglipron Canada: Update On the Newest Weight Loss Pill